Walgreen Company (WAG): Why Investors Should Not Give up on This Drug Retailer

Page 1 of 2

Walgreen Company (NYSE:WAG), along with its partnership with Alliance Boots, has strengthened its long-term position by working with AmerisourceBergen Corp. (NYSE:ABC) to become the world’s largest drug buyer. However, its short-term margin remains under pressure as reflected by the disappointing Q3 2013 results.

Results and concerns

Walgreen Company (NYSE:WAG)

Walgreen Company (NYSE:WAG) tumbled near 5.9% on June 25 after releasing Q3 adjusted earnings of $0.85 per share, which was below analysts’ estimated earnings of $0.91 per share. Due to a weaker British pound, Walgreen lowered its earnings expectation from Alliance Boosts for Q4 by a penny to $0.08 per share. For the full fiscal year, the adjusted EPS estimate was lowered to $0.16 from the previous estimate of $0.18 to $0.22.

The company’s margin will be negatively impacted by a trough in the generic wave, which is expected to continue until the latter half of fiscal 2014, and stronger promotion and pricing initiatives designed to drive traffic and front-end comps.

On the positive side, the company continues to be on track to deliver $125 million to $150 million in combined synergies from its joint-synergy program with Alliance Boots, which is on track with the previous target of $100 million to $150 million. Walgreen also generated strong cash flow of $1.4 billion with $1.1 billion in free cash flow.

What is Walgreen doing?

With its partnerships with Alliance Boots and AmerisourceBergen, Walgreen Company (NYSE:WAG) is strengthening its global sourcing ability, firming up its buying power of generic drugs and expanding its accessibility to specialized drugs. In June, Walgreen launched the Boots No 7 men’s product line in more than 5,000 stores, which is in addition to the successful No 7 women’s skincare line. With its new partnership with AmerisourceBergen Corp. (NYSE:ABC), Walgreen will begin new deliver models to optimize frequency and improve local assortments.

Walgreen Company (NYSE:WAG) is positioning itself for long-term growth by creating a better experience with a clear three-point plan. The company will adjust its pricing and promotion throughout Q4, focus on maximizing the value of its Balanced Rewards program and enhance its store segmentation to better serve the local needs.

Competition

Walgreen Company (NYSE:WAG) continues to win back Express Scripts Holding Company (NASDAQ:ESRX)’s customers and gain more new Medicare Part-D customers, as demonstrated by a 7.1% increase in its retail comp scripts.

CVS Caremark Corporation (NYSE:CVS), the largest integrated pharmacy company in United States and one of Walgreen Company (NYSE:WAG)’s major rivals, is targeting compound growth rates of 5% to 8% on the top line and 7% to flat performance in adjusted EPS for the five-year period ending 2015. CVS Caremark is improving its accessibility and lowering its overall healthcare costs to align with the direction in which healthcare is headed. CVS Caremark Corporation (NYSE:CVS) also expects to retain at least 60% of the 24 million gained scripts due to the Walgreen-Express Scripts dispute.

Page 1 of 2

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!